<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04071665</url>
  </required_header>
  <id_info>
    <org_study_id>NSFC 81702220</org_study_id>
    <nct_id>NCT04071665</nct_id>
  </id_info>
  <brief_title>A Modified Lateral Lumbar Interbody Fusion VS. Transforaminal Lumbar Interbody Fusion for Adult Degenerative Scoliosis</brief_title>
  <official_title>A Modified Lateral Lumbar Interbody Fusion VS. Transforaminal Lumbar Interbody Fusion for Adult Degenerative Scoliosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Shantou University Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shenzhen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A modified lateral lumbar interbody fusion VS. transforaminal lumbar interbody fusion for the
      treatment of adult degenerative scoliosis with 2 year follow-up with a multiple center,
      randomized case-control study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adult degenerative scoliosis (ADS) is the most common spinal deformity in the elderly, and
      the severe patients need surgical treatment. The elderly are often complicated with many
      medical diseases and the perioperative risk is high, so minimally invasive surgery is a new
      choice for spinal surgeons to treat ADS. Modified lateral lumbar interbody fusion (CLIF) is
      an new modified spinal minimally invasive interbody fusion technique in the investigator's
      department. The results of preliminary studies showed that it has the advantages of less
      trauma, short operation time and fewer complications, and the clinical and imaging outcome
      are remarkable. Therefore, the present study aims to establish a multicenter, large sample
      prospective randomized controlled study to explore the technical advantages and surgical
      indications of the new technique in the treatment of ADS by comparing with the traditional
      posterior spinal interbody fusion; (2) to compare the postoperative clinical and imaging
      results and analyze the surgical complications and preventive measures; (3) to establish a
      long-term follow-up to further quantify the clinical and imaging outcome of the new
      technique. Therefore, this study will further verify the safety and effectiveness of the CLIF
      in the treatment of ADS on the basis of previous studies, and provide a new clinical approach
      for minimally invasive treatment of ADS.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ODI score</measure>
    <time_frame>2 years</time_frame>
    <description>an index for assessing the lower back pain wiith multiple questionnare</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Degenerative Scoliosis</condition>
  <condition>Minimally Invasive</condition>
  <condition>Spinal Deformity</condition>
  <arm_group>
    <arm_group_label>Modified lateral lumbar interbody fusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Modified lateral lumbar interbody fusion for treatment of scoliosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>transforaminal lumbar interbody fusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>transforaminal lumbar interbody fusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Modified lateral lumbar interbody fusion</intervention_name>
    <description>Modified lateral lumbar interbody fusion</description>
    <arm_group_label>Modified lateral lumbar interbody fusion</arm_group_label>
    <arm_group_label>transforaminal lumbar interbody fusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least 50 years of age, diagnosed with adult thoracolumbar scoliosis including any
             number of intervertebral levels between T8 and S1, unresponsive to conservative
             treatment for at least 6 months, and had a preoperative coronal Cobb angle of at least
             10° and preoperative ODI score of at least 30%.

        Exclusion Criteria:

          -  with prior lumbar fusion surgery or spondylolisthesis greater than Grade II
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qixin CHEN, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Orthopedics Department, 2nd Hospital, School of Medicine, Zhejiang University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fangcai LI, Ph.D</last_name>
    <phone>86-057187784594</phone>
    <email>89048991@qq.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhiwei WANG, Ph.D</last_name>
    <phone>86-057187784594</phone>
    <email>wangzhiwei929@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Second Affiliated Hospital, School of Medicine, Zejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhiwei Wang, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Mendoza-Lattes S. Cervical Disc Replacement: Are We There Yet? Commentary on an article by Michael E. Janssen, DO, et al.: &quot;ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease. Seven-Year Follow-up of the Prospective Randomized U.S. Food and Drug Administration Investigational Device Exemption Study&quot;. J Bone Joint Surg Am. 2015 Nov 4;97(21):e71. doi: 10.2106/JBJS.O.00750.</citation>
    <PMID>26537171</PMID>
  </reference>
  <reference>
    <citation>Kretzer RM. Adult Degenerative Spinal Deformity: Overview and Open Approaches for Treatment. Spine (Phila Pa 1976). 2017 Apr 1;42 Suppl 7:S16. doi: 10.1097/BRS.0000000000002028. Review.</citation>
    <PMID>28296697</PMID>
  </reference>
  <reference>
    <citation>Bach K, Ahmadian A, Deukmedjian A, Uribe JS. Minimally invasive surgical techniques in adult degenerative spinal deformity: a systematic review. Clin Orthop Relat Res. 2014 Jun;472(6):1749-61. doi: 10.1007/s11999-013-3441-5. Review.</citation>
    <PMID>24488750</PMID>
  </reference>
  <results_reference>
    <citation>Epstein NE. Commentary on: Laminectomy plus fusion versus laminectomy alone for lumbar spondylolisthesis by Ghogawala Z, Dziura J, Butler WE, Dai F, Terrin N, Magge SN, et al. NEJM 2016;374 (15):1424-34. Surg Neurol Int. 2016 Sep 22;7(Suppl 25):S644-S647. eCollection 2016.</citation>
    <PMID>27843677</PMID>
  </results_reference>
  <results_reference>
    <citation>Epstein NE. Commentary on: A randomized controlled trial of fusion surgery for lumbar spinal stenosis (Forsth P, Ólafsson G, Carlsson T, Frost A, Borgström F, Fritzell P, et al. N Eng J Med 2016;374:1414-23). Surg Neurol Int. 2016 Sep 22;7(Suppl 25):S641-S643. eCollection 2016.</citation>
    <PMID>27843676</PMID>
  </results_reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>August 26, 2019</study_first_submitted>
  <study_first_submitted_qc>August 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2019</study_first_posted>
  <last_update_submitted>May 10, 2020</last_update_submitted>
  <last_update_submitted_qc>May 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scoliosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>after complete the recruiment with half of participants, we will share the preliminary results with data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

